Previous studies, including our own, have demonstrated that stromal cell components play a critical role in OSCC bone invasion by modulating tumor invasiveness, epithelial–mesenchymal transition (EMT), and the expression of RANKL and parathyroid hormone-related peptide (PTHrP) [8,9]. Here, PTHLH is linked to neoplasm.